Svizera Labs Private Limited — Rifampicin Exporter Profile
Indian Pharmaceutical Exporter · #5 for Rifampicin · $3.9M export value · DGFT Verified
Svizera Labs Private Limited is the #5 Indian exporter of Rifampicin with $3.9M in export value and 77 verified shipments. Svizera Labs Private Limited holds a 0.3% market share in Rifampicin exports across 16 countries. The company exports 5 pharmaceutical products worth $13.7M across 3 therapeutic categories.
Svizera Labs Private Limited — Rifampicin Export Profile: Buyers & Destinations
Where Does Svizera Labs Private Limited Export Rifampicin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NIGERIA | $1.7M | 34 | 56.0% |
| VENEZUELA | $365.2K | 8 | 12.0% |
| NEPAL | $154.0K | 4 | 5.1% |
| TANZANIA | $100.0K | 2 | 3.3% |
| NAMIBIA | $100.0K | 2 | 3.3% |
| MYANMAR | $100.0K | 2 | 3.3% |
| CONGO | $100.0K | 2 | 3.3% |
| NETHERLANDS | $88.4K | 10 | 2.9% |
| NICARAGUA | $79.1K | 2 | 2.6% |
| FRANCE | $52.9K | 2 | 1.7% |
Svizera Labs Private Limited exports Rifampicin to 16 countries. The largest destination is NIGERIA accounting for 56.0% of Svizera Labs Private Limited's Rifampicin shipments, followed by VENEZUELA (12.0%) and NEPAL (5.1%). These destinations reflect Svizera Labs Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Rifampicin from Svizera Labs Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| DR LABARAN SHEHU | NIGERIA | $1.1M | 22 |
| NATIONAL TUBERCULOSIS AND LEPROSY | NIGERIA | $600.0K | 12 |
| MAR?A LISSETT GARC?A ROBLES | VENEZUELA | $275.8K | 6 |
| TO THE ORDER OF | NEPAL | $150.0K | 3 |
| ERF. 492, DANTE STREET | NAMIBIA | $100.0K | 2 |
| UNOPS | MYANMAR | $100.0K | 2 |
| COUNTRY REPUBLIQUE DU CONGO | CONGO | $100.0K | 2 |
| MARIA LISSETT GARCIA ROBLES PROCUR | VENEZUELA | $89.4K | 2 |
| CENTRO DE INSUMOS PARA LA SALUD | NICARAGUA | $79.1K | 2 |
| LABORATOIRES LAFRAN | FRANCE | $52.9K | 2 |
Svizera Labs Private Limited supplies Rifampicin to 24 buyers globally. The largest buyer is DR LABARAN SHEHU (NIGERIA), followed by NATIONAL TUBERCULOSIS AND LEPROSY (NIGERIA) and MAR?A LISSETT GARC?A ROBLES (VENEZUELA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Rifampicin Export Value and How Much Does Svizera Labs Private Limited Contribute?
India exported $121.8M worth of Rifampicin through 3,913 shipments from 175 suppliers to 162 countries, serving 780 buyers globally. Svizera Labs Private Limited contributes $3.9M to this total, accounting for 0.3% of India's Rifampicin exports. Svizera Labs Private Limited ships Rifampicin to 16 countries through 24 buyers.
What Is the Average Shipment Value for Svizera Labs Private Limited's Rifampicin Exports?
Svizera Labs Private Limited's average Rifampicin shipment value is $50.0K per consignment, based on 77 shipments totaling $3.9M. The largest destination is NIGERIA (56.0% of Svizera Labs Private Limited's Rifampicin exports).
How Does Svizera Labs Private Limited Compare to Other Indian Rifampicin Exporters?
Svizera Labs Private Limited ranks #5 among 175 Indian Rifampicin exporters with a 0.3% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($64.0M), MACLEODS PHARMACEUTICALS LIMITED ($18.5M), LUPIN LIMITED ($18.4M). Svizera Labs Private Limited processed 77 shipments to 16 destination countries.
What Rifampicin Formulations Does Svizera Labs Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| 12 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ ISONIAZID 75 MG TABLETS(6431X12) | $300.0K | 6 |
| 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150MG/ISONIAZID 75 MG/ PYRAZINAMIDE 400MG/ETHAMBUTOL HCL 275MG TABLETS(6431X6) | $300.0K | 6 |
| RIFAMPICIN 150MG / ISONIAZID 75MG TABS EACH CARTON OF 24x28 TABS | $242.5K | 9 |
| RIFAMPICIN 150MG/ISONIAZID 75MG/PYRAZINAMIDE 400MG/ETHAMBUTOL HCL 275MG TABS,EACH CARTON OF 24X28 TABS | $150.0K | 3 |
| 12 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ ISONIAZID 75 MG TABLETS (6430x12 = 77160 strips) | $150.0K | 3 |
| 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ISONIAZID 75 MG/PYRAZINAMIDE 400MG/ETHAMBUTOL HCL 275MG TABLETS(6430x6 | $150.0K | 3 |
| RIFAMPICIN 150 MG/ ISONIAZID 75 MG / PYRAZINAMIDE 400MG / ETHAMBUTOL HCL 275MG TABLETS (QTY. 6430X6 = 38580 STRIPS) | $150.0K | 3 |
| RIFAMPICIN 150 MG/ ISONIAZID 75 MG TABLETS (QTY. 6430X12 = 77160 STRIPS) | $150.0K | 3 |
| RIFAMPICIN 150MG / ISONIAZID 75MG / PYRAZINAMIDE 400MG /ETHAMBUTOL HCL 275MG TABS EACH CARTON OF 24x28 TABS | $125.7K | 5 |
| 12 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ ISONIAZID 75 MG TABLETS (6431x12 = 77172 strips) | $100.0K | 2 |
Svizera Labs Private Limited exports 39 distinct Rifampicin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is 12 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ ISONIAZID with 6 shipments worth $300.0K.
Regulatory Requirements: Exporting Rifampicin to Key Markets
What Svizera Labs Private Limited must comply with to export Rifampicin to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Svizera Labs Private Limited Compare to Nearest Rifampicin Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | LUPIN LIMITED | $18.4M | 369 | 58 | $50.0K |
| 4 | MANEESH PHARMACEUTICALS LIMITED | $10.3M | 207 | 41 | $50.0K |
| 5 | SVIZERA LABS PRIVATE LIMITED ★ | $3.9M | 77 | 16 | $50.0K |
| 8 | SANDOZ PRIVATE LIMITED | $1.5M | 57 | 11 | $27.1K |
| 6 | OMNICALS PHARMA PRIVATE LIMITED | $1.4M | 29 | 5 | $50.0K |
Svizera Labs Private Limited ranks #5 among 175 Indian Rifampicin exporters. Average shipment value of $50.0K compared to the market average of $696.0K. The closest competitors by value are LUPIN LIMITED and MANEESH PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Rifampicin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 947 | 24.2% |
| SAHAR AIR | 813 | 20.8% |
| DELHI AIR CARGO ACC (INDEL4) | 477 | 12.2% |
| DELHI AIR | 404 | 10.3% |
| NHAVA SHEVA SEA (INNSA1) | 295 | 7.5% |
| Bombay Air | 175 | 4.5% |
| JNPT/ NHAVA SHEVA SEA | 116 | 3.0% |
| JNPT | 99 | 2.5% |
Geopolitical & Trade Policy Impact on Svizera Labs Private Limited's Rifampicin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Svizera Labs. The escalation of conflicts in the Middle East, particularly the 2026 Strait of Hormuz crisis, has led to significant disruptions in vital trade corridors. Shipping routes through the Red Sea and the Suez Canal have been compromised, resulting in longer transit times and increased freight costs. For instance, diversions around the Cape of Good Hope have added 10–20 days to transit times and raised freight rates by 40–50% on key India–Europe routes. (livemint.com) These disruptions pose logistical challenges for time-sensitive pharmaceutical shipments, potentially affecting Svizera's export efficiency and cost structures.
Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to expand their footprint in markets seeking alternative suppliers. Svizera Labs can capitalize on this shift by strengthening its presence in regions looking to diversify their pharmaceutical import sources. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains imperative. The FMD mandates stringent serialization and traceability requirements, necessitating investments in technology and processes to ensure compliance and maintain access to the lucrative EU market.
Svizera Labs Private Limited — Regulatory Compliance & Quality Standards
The regulatory environment for pharmaceutical exports is becoming increasingly stringent, with agencies like the U.S. Food and Drug Administration (FDA), WHO, and the European Medicines Agency (EMA) enforcing rigorous Good Manufacturing Practice (GMP) standards. Svizera Labs' previous suspension by the WHO in 2016 highlights the critical importance of maintaining compliance with these standards. The successful lifting of the suspension in 2018 demonstrates the company's commitment to quality improvement. Continuous adherence to evolving regulatory requirements is essential for sustaining market access and competitiveness.
About Svizera Labs Private Limited
Svizera Labs Private Limited exports 5 products worth $13.7M. Beyond Rifampicin, top products include Isoniazid, Ethambutol, Pyrazinamide, Strip. View the complete Svizera Labs Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rifampicin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rifampicin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Svizera Labs Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 77 individual customs records matching Svizera Labs Private Limited exporting Rifampicin, covering 39 formulations to 16 countries via 24 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 162+ countries, 780+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rifampicin Export Data from Svizera Labs Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Svizera Labs Private Limited's Rifampicin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Svizera Labs Private Limited
Full Company Profile →
5 products · $13.7M total trade · 3 categories
Rifampicin Stats
Company Overview
Top Products by Svizera Labs Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Svizera Labs Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rifampicin. For current shipment-level data, contact TransData Nexus.